Systems and methods are provided for delivering one or more drugs. In some embodiments, a drug delivery system includes a housing having a distal end with an inlet through which an inspiratory flow of air passes into the housing, a proximal end having a patient interface attached thereto, the patient interface being configured to interface with a user, and an inspiratory flow pathway extending from the distal end to the proximal end of the housing. A nitric oxide (NO) source is positioned within the housing and is configured to deliver NO-containing gas to the patient interface. A secondary drug source is positioned within the housing and is configured to deliver a secondary drug to the patient interface. A controller is configured to control an amount of NO-containing gas and an amount of the secondary drug delivered using a control scheme.

A system for delivering a therapeutic amount of nitric oxide can include a reservoir containing a nitrogen dioxide source. A heating element can be configured to heat the reservoir, causing nitrogen dioxide vapor to exit the reservoir through a restrictor into a conduit. The nitrogen dioxide vapor can mix with gas from a gas supply, which can then flow to a cartridge that includes a surface-activated material saturated with an aqueous solution of a reducing agent. The cartridge can convert the nitrogen dioxide into nitric oxide.

A flow of air is directed at the face and into the nose and mouth so as to decrease taste and inhibit appetite.

A high flow therapy system for delivering heated and humidified respiratory gas to an airway of a patient, the system including a respiratory gas flow pathway for delivering the respiratory gas to the airway of the patient by way of a non-sealing respiratory interface; wherein flow rate of the pressurized respiratory gas is controlled by a microprocessor.

The present disclosure describes a pressure support therapy device valve that enables a subject to safely supplement therapy pressure support with low flow oxygen while using a heated (or non-heated) tube. The valve conducts a pressurized flow of breathable gas and the low flow oxygen to the heated tube. The valve includes electrical components configured to pass power from the pressure support therapy device to the heated tube, and a plunger biased to close a flow path from the pressure support therapy device when a pressurized flow of breathable gas is not provided (or is below a predetermined pressure threshold). Closing the flow path stops oxygen gas from flowing back through the valve toward the pressurized gas source.

The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO.sub.2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO.sub.2-to-NO reactor cartridge and/or a breakthrough of NO.sub.2, and providing an indication of the remaining useful life and/or breakthrough.

An aspect provides a ventilation manifold for a ventilator, the manifold comprising a fluid flow path, the flow path comprising: bifurcated end paths, a constriction path and a compressed breathable gas chamber fluidly coupled to a compressed breathable gas source, the manifold having a manifold axis defined by the constriction path; a source path of the bifurcated ends coupled to an outlet conduit for a ventilator to present the compressed breathable gas at a source angle to one side of the manifold axis; and a vent path at a vent angle to the manifold axis for an exhaust flow, the vent path acting to provide a fluid pressure valve upon an inlet compressed breathable gas from the constriction path to urge flow towards the source path and a by-pass for returned outlet spent gas flow from the source path against the inlet compressed breathable gas at the constriction path, the fluid pressure valve and the by-pass dependent upon the relative magnitudes of the source angle and the vent angle to the manifold axis and/or each other along with the configuration of the constriction path and/or the configuration of the source path and/or the vent path.

Methods and systems for capturing capnography data during high-flow oxygen therapy (HFOT) are disclosed. An example method includes delivering HFOT by delivering breathing gases at an operational flow rate and an operational oxygen concentration level; initiating a temporary flow-reduction function for a set duration, wherein breathing gases are delivered at a temporary flow rate for the set duration, the temporary flow rate being less than the operational flow rate; capturing capnography data for exhaled air during the set duration; and upon expiration of the set duration, resuming HFOT delivery.

Provided herein are systems and methods for delivery of therapeutic gas to patients, in need thereof, by receiving breathing gas from a high frequency ventilator using at least enhanced therapeutic gas (e.g., nitric oxide, NO, etc.) flow measurement. At least some of these enhanced therapeutic gas flow measurements can be used to address some surprising phenomenon that may, at times, occur when wild stream blending therapeutic gas into breathing gas a patient receives from a breathing circuit affiliated with a high frequency ventilator. Utilizing at least some of these enhanced therapeutic gas flow measurements the dose of therapeutic gas wild stream blended into breathing gas that the patient receives can at least be more accurate and/or under delivery of therapeutic gas into the breathing gas can be avoided and/or reduced.

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.